{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Atherosclerotic+Coronary+Vascular+Disease&page=4", "query": { "condition": "Atherosclerotic Coronary Vascular Disease", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 92, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Atherosclerotic+Coronary+Vascular+Disease&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Atherosclerotic+Coronary+Vascular+Disease&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T18:45:58.491Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02915198", "title": "Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Prediabetic State", "Atherosclerosis", "Metformin" ], "interventions": [ { "name": "Metformin XR", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7410, "start_date": "2023-04-03", "completion_date": "2029-09-28", "has_results": false, "last_update_posted_date": "2025-12-17", "last_synced_at": "2026-10-22T18:45:58.491Z", "location_count": 40, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Little Rock, Arkansas + 37 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Loma Linda", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02915198" }, { "nct_id": "NCT05994014", "title": "PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease", "Atherosclerosis", "Coronary Atherosclerosis of Native Coronary Artery" ], "interventions": [ { "name": "PET/CT", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 33, "start_date": "2023-07-01", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-06-09", "last_synced_at": "2026-10-22T18:45:58.491Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05994014" }, { "nct_id": "NCT00240318", "title": "A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Coronary Arteriosclerosis" ], "interventions": [ { "name": "Rosuvastatin calcium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 450, "start_date": "2002-11", "completion_date": "2005-11", "has_results": false, "last_update_posted_date": "2010-11-19", "last_synced_at": "2026-10-22T18:45:58.491Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Francisco, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Santa Rosa", "state": "California" }, { "city": "Stockton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00240318" }, { "nct_id": "NCT07141914", "title": "A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real World", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Overweight", "Obesity", "Heart Failure (HF)", "Atherosclerotic Cardiovascular Disease (ASCVD)", "Primary Prevention" ], "interventions": [ { "name": "No treatment given", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 285327, "start_date": "2025-08-29", "completion_date": "2025-12-19", "has_results": false, "last_update_posted_date": "2026-01-23", "last_synced_at": "2026-10-22T18:45:58.491Z", "location_count": 1, "location_summary": "Plainsboro, New Jersey", "locations": [ { "city": "Plainsboro", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT07141914" }, { "nct_id": "NCT03897478", "title": "Biomarkers of Acute Stroke in Clinic", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Ischemic Stroke", "Ischemia", "Atrial Fibrillation", "Transient Ischemic Attack", "Transient Cerebrovascular Events", "Thrombotic Stroke", "Stroke", "Stroke, Acute", "Stroke, Ischemic", "Stroke, Complication", "Stroke of Basilar Artery", "Atherosclerosis", "Atheroma", "Cardioembolic Stroke", "Cardiomyopathies", "Cardiovascular Stroke", "Thromboembolism" ], "interventions": [ { "name": "ISCDX blood test", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Ischemia Care LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 500, "start_date": "2019-04-01", "completion_date": "2024-12-31", "has_results": false, "last_update_posted_date": "2023-09-28", "last_synced_at": "2026-10-22T18:45:58.491Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03897478" }, { "nct_id": "NCT04462159", "title": "The Young Heart Study", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atherosclerotic Cardiovascular Disease", "Coronary Artery Disease" ], "interventions": [ { "name": "Risk Reduction Program", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "59 Years", "sex": "ALL", "summary": "18 Years to 59 Years" }, "enrollment_count": 60, "start_date": "2020-05-27", "completion_date": "2026-05-27", "has_results": false, "last_update_posted_date": "2023-11-01", "last_synced_at": "2026-10-22T18:45:58.491Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04462159" }, { "nct_id": "NCT04873934", "title": "Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Coronary Syndrome" ], "interventions": [ { "name": "Inclisiran", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 400, "start_date": "2021-06-24", "completion_date": "2024-08-07", "has_results": true, "last_update_posted_date": "2025-10-16", "last_synced_at": "2026-10-22T18:45:58.491Z", "location_count": 88, "location_summary": "Jonesboro, Arkansas • Bakersfield, California • Fresno, California + 75 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Bakersfield", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Santa Rosa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04873934" }, { "nct_id": "NCT06855394", "title": "Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Atherosclerotic Vascular Disease", "Coronary Arterial Disease (CAD)", "Atherosclerosis of Coronary Artery", "Atherosclerosis of Arteries of the Extremities, Unspecified", "Heart Diseases", "Stroke", "Venous Thromboembolic Disease" ], "interventions": [], "intervention_types": [], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 13000, "start_date": "2011-01-01", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-03-31", "last_synced_at": "2026-10-22T18:45:58.491Z", "location_count": 2, "location_summary": "Gainesville, Florida • Jacksonville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06855394" }, { "nct_id": "NCT03350542", "title": "A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "SYNERGY 48 mm", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Boston Scientific Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2018-04-12", "completion_date": "2021-01-08", "has_results": true, "last_update_posted_date": "2021-05-14", "last_synced_at": "2026-10-22T18:45:58.491Z", "location_count": 8, "location_summary": "Birmingham, Alabama • Saint Paul, Minnesota • New York, New York + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Saint Paul", "state": "Minnesota" }, { "city": "New York", "state": "New York" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03350542" }, { "nct_id": "NCT02316886", "title": "Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Coronary Artery Disease", "Plaque, Atherosclerotic" ], "interventions": [ { "name": "Coronary intervention", "type": "DEVICE" }, { "name": "Optimal Medical treatment", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Seung-Jung Park", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1608, "start_date": "2015-10-05", "completion_date": "2023-10-19", "has_results": false, "last_update_posted_date": "2023-11-18", "last_synced_at": "2026-10-22T18:45:58.491Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02316886" } ] }